Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Johnson and Johnson
McKesson
Colorcon
Express Scripts

Last Updated: August 11, 2022

EZALLOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Ezallor, and what generic alternatives are available?

Ezallor is a drug marketed by Sun Pharm and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in EZALLOR is rosuvastatin calcium. There are forty-two drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the rosuvastatin calcium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ezallor

A generic version of EZALLOR was approved as rosuvastatin calcium by WATSON LABS INC on April 29th, 2016.

  Try it Free

US Patents and Regulatory Information for EZALLOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm EZALLOR SPRINKLE rosuvastatin calcium CAPSULE;ORAL 208647-001 Dec 18, 2018 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Sun Pharm EZALLOR SPRINKLE rosuvastatin calcium CAPSULE;ORAL 208647-004 Dec 18, 2018 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Sun Pharm EZALLOR SPRINKLE rosuvastatin calcium CAPSULE;ORAL 208647-002 Dec 18, 2018 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Sun Pharm EZALLOR SPRINKLE rosuvastatin calcium CAPSULE;ORAL 208647-003 Dec 18, 2018 RX Yes No See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Mallinckrodt
McKinsey
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.